Related Experiment Video
Updated: Jul 27, 2026

Quantitative Comparison of cis-Regulatory Element (CRE) Activities in Transgenic Drosophila melanogaster
Published on: December 19, 2011
Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation
1Department of Genetics, University of Bayreuth, 95440 Bayreuth, Germany.
Abstract:
The Cre/loxP site-specific recombination system has been used successfully for genome manipulation in a wide range of species. However, in Drosophila melanogaster, a major model organism for genetic analyses, the alternative FLP/FRT system, which is less efficient at least in mammalian cells, has been established, primarily for the generation of genetic mosaics for clonal analyses. To extend genetic methodology in D. melanogaster, we have created transgenic lines allowing tissue-specific expression of Cre recombinase with the UAS/GAL4 system. Surprisingly, chronic expression of Cre recombinase from these transgenes (UAST-cre) was found to be toxic for proliferating cells. Therefore, we also generated transgenic lines allowing the expression of Cre recombinase fused to the ligand-binding domain of the human estrogen receptor (UASP-cre-EBD). We demonstrate that recombination can be efficiently dissociated from toxicity by estrogen-dependent regulation of recombinase activity of the UASP-cre-EBD transgene products.
Insights
Researchers developed new Cre recombinase tools for Drosophila melanogaster, overcoming toxicity issues associated with chronic expression. The estrogen-dependent Cre-Estrogen Binding Domain (Cre-EBD) system allows controlled recombination, enhancing genetic manipulation in this model organism.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- The Cre/loxP system is a powerful tool for genome engineering across species.
- Drosophila melanogaster primarily uses the FLP/FRT system for generating genetic mosaics.
- Existing Cre/loxP tools in Drosophila have limitations, particularly regarding cell toxicity.
Purpose of the Study:
- To develop novel Cre recombinase tools for enhanced genetic manipulation in Drosophila melanogaster.
- To overcome the toxicity associated with constitutive Cre recombinase expression in proliferating cells.
- To establish an inducible and controllable Cre/loxP system for Drosophila research.
Main Methods:
- Generation of transgenic Drosophila lines expressing Cre recombinase under the UAS/GAL4 system (UAST-cre).
- Development of a modified Cre recombinase fused to the estrogen receptor binding domain (UASP-cre-EBD).
- Assessment of Cre recombinase activity and cellular toxicity in response to estrogen treatment.
Main Results:
- Constitutive expression of Cre recombinase (UAST-cre) demonstrated toxicity in proliferating Drosophila cells.
- The Cre-Estrogen Binding Domain (Cre-EBD) fusion protein enabled estrogen-dependent Cre recombinase activity.
- Estrogen-mediated regulation effectively dissociated Cre recombinase activity from cellular toxicity.
Conclusions:
- The UASP-cre-EBD system provides a safer and more controllable method for site-specific recombination in Drosophila.
- This new system expands the genetic toolkit for Drosophila melanogaster, facilitating advanced clonal analysis and genome engineering.
- Estrogen-inducible Cre recombinase activity offers a significant improvement over constitutive systems for studying gene function in vivo.
Related Concept Videos
Negative Regulator Molecules
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...

